UBS AM
PLSE icon

UBS AM’s Pulse Biosciences PLSE Stock Holding History

UBS AM’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$687K Buy
31,820
+1,119
+4% +$20.7K ﹤0.01% 2465
2025
Q4 		$422K Buy
30,701
+225
+0.7% +$3.51K ﹤0.01% 2356
2025
Q3 		$539K Sell
30,476
-17,855
-37% -$282K ﹤0.01% 2148
2025
Q2 		$729K Buy
48,331
+11,800
+32% +$196K ﹤0.01% 2443
2025
Q1 		$588K Sell
36,531
-1,777
-5% -$33.1K ﹤0.01% 2463
2024
Q4 		$667K Buy
38,308
+4,773
+14% +$84.1K ﹤0.01% 2501
2024
Q3 		$588K Buy
+33,535
New +$572K ﹤0.01% 2604

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

UBS AM's PLSE Position: Q1 2026 in Review

UBS AM increased its Pulse Biosciences (PLSE) stake by 3.6% in Q1 2026, buying an estimated $20.7K and bringing the position to 31,820 shares worth $687K. The position accounts for ﹤0.01% of the portfolio, ranked #2465.

UBS AM first reported a position in PLSE in Q3 2024 and has held it in 7 quarters since. The position peaked at $729K in Q2 2025. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • UBS AM held 31,820 shares of Pulse Biosciences worth $687K as of Q1 2026.
  • UBS AM bought 1,119 Pulse Biosciences shares in Q1 2026, an estimated $20.7K.
  • Pulse Biosciences made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #2465 holding.
  • UBS AM first reported a position in Pulse Biosciences in Q3 2024 and has held it in 7 quarters since.
  • UBS AM's Pulse Biosciences position peaked at $729K in Q2 2025.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.